Literature DB >> 3546246

Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus.

E Bergogne-Berezin, M L Joly-Guillou.   

Abstract

Imipenem was the most active drug against Acinetobacter, even against strains possessing beta-lactamases. MICs of imipenem for 50% and 90% of the A. calcoaceticus (var. anitratum) were 0.28 and 0.61 mg/l respectively whereas for ceftazidime they were 4.4 and 10.0, and for cefotaxime, 7.9 and 22.2 mg/l. No change occurred in the in-vitro activity of imipenem against Acinetobacter, during the period 1980-1985. Geometric mean MICs in 1985 were 0.33 mg/l for A. calcoaceticus var. anitratum; the values were lower for A. calcoaceticus var. lwoffi. Ceftazidime and cefotaxime MICs were also stable from 1981 to 1985, but the values were higher, geometric mean MICs being 5.3 and 10.1 mg/l respectively. MBCs of imipenem for A. calcoaceticus var. anitratum ranged from 0.194 to 0.35 mg/l; the ratio MBC/MIC was 1.17.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3546246     DOI: 10.1093/jac/18.supplement_e.35

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii.

Authors:  G Bou; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.

Authors:  S Bajaksouzian; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Authors:  M A Visalli; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 4.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

5.  Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.

Authors:  M A Visalli; M R Jacobs; T D Moore; F A Renzi; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

6.  Antimicrobial susceptibility of Acinetobacter species.

Authors:  H Seifert; R Baginski; A Schulze; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.